Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder

BACKGROUND: A double blind, placebo-controlled randomized trial (NCT00253747) evaluating osmotic-release oral system methylphenidate (OROS-MPH) for smoking-cessation revealed a significant interaction effect in which participants with higher baseline ADHD severity had better abstinence outcomes with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Drug Alcohol Abuse
Autors principals: Luo, Sean X., Wall, Melanie, Covey, Lirio, Hu, Mei-Chen, Scodes, Jennifer M., Levin, Frances R., Nunes, Edward V., Winhusen, Theresa
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6060016/
https://ncbi.nlm.nih.gov/pubmed/29370538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2017.1416474
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars